Related Experiment Video
Updated: Oct 23, 2025

Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors
Published on: October 9, 2016
Inhibition of Streptococcus mutans biofilms with bacterial-derived outer membrane vesicles
Yihui Wang1, Joseph P Hoffmann1, Sarah M Baker1
1Department of Microbiology and Immunology, Tulane University School of Medicine, 1430 Tulane Ave., SL-38, LA, 70112-2699, New Orleans, USA.
Outer membrane vesicles (OMVs) from Burkholderia thailandensis effectively disrupt Streptococcus mutans biofilms. These bacterial nanoparticles enhance antibiotic efficacy, offering a novel strategy against resistant oral pathogens.
Area of Science:
- Microbiology
- Nanotechnology
- Drug Discovery
Background:
- Biofilms present a significant challenge in treating bacterial infections due to increased antibiotic resistance.
- Outer membrane vesicles (OMVs) are nanoparticles produced by Gram-negative bacteria involved in various cellular processes.
- Previous research demonstrated the antimicrobial properties of Burkholderia thailandensis OMVs against diverse microbes.
Purpose of the Study:
- To investigate the antibiofilm efficacy of Burkholderia thailandensis OMVs against Streptococcus mutans, a key oral pathogen.
- To identify the components within OMVs responsible for their antibiofilm activity.
- To assess the potential of OMVs in combination therapy to enhance antibiotic effectiveness.
Main Methods:
- Treatment of Streptococcus mutans biofilms with Burkholderia thailandensis OMVs.
- Assessment of biofilm biomass, integrity, and bacterial viability post-treatment.
- Analysis of heat-labile and heat-stable OMV components, including quinoline and rhamnolipid.
- Evaluation of combined OMV and gentamicin treatment efficacy.
Main Results:
- OMV treatment significantly reduced Streptococcus mutans biofilm biomass, integrity, and bacterial viability.
- Both heat-labile and heat-stable OMV components, specifically 4-hydroxy-3-methyl-2-(2-non-enyl)-quinoline and rhamnolipid, contribute to antibiofilm activity.
- Co-administration of OMVs with gentamicin enhanced the antibiotic's efficacy against S. mutans biofilms.
Conclusions:
- Bacterial-derived OMVs are potent biological nanoparticles with significant antibiofilm capabilities.
- OMVs show promise as a novel therapeutic strategy for inhibiting and eradicating biofilms.
- The synergistic effect with conventional antibiotics highlights the potential of OMVs in combating resistant infections.
More Related Videos
Related Concept Videos
Biofilms
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Biological Methods for Microbial Control
Outer Layers of the Cell Envelope
Gene Regulation in Microbial Communities: Quorum Sensing

